- E-mail: email@example.com
- Tel: +7 (495) 956 00 33
- Free hotline: 8 (800) 250 09 21
Trained as a corporate lawyer in Tel-Aviv and completed an MBA in finance at NYU. As part of the founding team at Hadasit Bio, was part of the IPO and led the company during 5 subsequent rounds of financing (totaling approx. $ 25 M), via Conv. Bonds, PIPE's, rights and secondary offerings.
The portfolio companies have raised under his guidance an additional $ 20 M including 6 strategic partnerships and investments from some of the leading VCs and institutional investors in Israel. Completed an ADR listing on the OTC (with full IR/PR support in conferences, newsletters, social networks etc.) and successfully completed 5 clinical trials (up to Ph. IIb) as well as various regulatory approvals within the portfolio.
Leadership of a portfolio of biotechnology companies through these complex challenges has strengthened a solid bio/financial skill that was acquired while serving as part of the founding team at Clal Biotechnology - Israel’s largest investor in life sciences and as VP BD at Protalix, traded on Amex.
Served as CEO of a Med. Dev. company in the Ultrasound space that was taken public on NASDAQ. Also, VP BD of a leading Digital Health investor, responsible for deal flow, due diligence, negotiations and other operational aspects of the holding co. and the portfolio.
A native English speaker with legal, financial and scientific education, and 18 years of experience working within the life science industry (BD and CEO of private / public / institutional co.). Based in Tel-Aviv, father of 3, long distance runner and enjoys skiing and cooking.